15.Issue 02 february 25 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 12, Issue : 02, February – 2025

Title:

NEWADVANCEMENTS OF PHARMACEUTICALANALYSIS BY IR, NMR, UV- VISIBLE SPECTROSCOPY
‬

Authors :

Chandana.Mannepali, Chennupati. V. Suresh, M. Manisha, M. Sudhamani, K. Pavani, G. Uday Kiran

Abstract :

The advancement of spectroscopic techniques, particularly Infrared (IR), Nuclear Magnetic Resonance (NMR), and UV-Visible spectroscopy, has significantly transformed pharmaceutical analysis. These methods offer powerful, non-destructive means to characterize and quantify pharmaceutical compounds with high precision. Infrared spectroscopy, especially with theadvent of Fourier Transform Infrared (FTIR) and Attenuated Total Reflectance (ATR), has enhanced the ability to identify functional groups, detect polymorphs, and analyze raw materials and formulations. Nuclear Magnetic Resonance (NMR) spectroscopy, through innovations such as high-resolution and multidimensional NMR techniques, provides detailed structural elucidation, ensuring the purity and stability of drugs while facilitating the development of new pharmaceutical entities. UV-Visible spectroscopy has evolved with miniaturized, portable devices and multivariate analysis techniques, enabling rapid, real-time quality control and quantification of active ingredients in drug formulations. Together, these spectroscopic advancement sarecrucialin improving the efficiency of pharmaceutical development, enhancing regulatory compliance, and ensuring the quality, safety, and efficacy of pharmaceutical products in both research and production environments.
Key Words: Pharmaceutical Analysis, Structural Elucidation, Drug Formulation, Infrared Spectroscopy, Nuclear Magnetic Resonance.

Cite This Article:

Please cite this article in press Chandana.Mannepali et al., New advancements Of Pharmaceutical analysis By IR, NMR, UV- Visible Spectroscopy.,Indo Am. J. P. Sci, 2025; 12 (02).

Number of Downloads : 10

References:

1. G.VIDYASAGAR a textbook of Instrumental methods of Drug Analysis, New age International Publishers.
2. ASHUTOSH KAR a text book of Pharmaceutical Drug Analysis , third revised edition, New age International Publishers.
3. GURDEEPR.CHATWAL,SHAMK.ANAND,a text book of Instrumental methods of chemical Analysis, Fifth revised and enlarged edition 2002, Himalaya publishing House.
4. “InfraredSpectroscopy”.ColourLex.12March2021.Retrieved 19January 2022.
5. DerrickMR,StulikD,LandryJM(1999). InfraredSpectroscopyinConservation Science (PDF). Scientific Tools for Conservation. Getty Publications. ISBN 0 -89236-469-6.
6. Ricciardi P. “Unlocking the secrets of illuminated manuscripts”. Retrieved11 December 2015.
7. Lau WS (1999). Infrared characterization for microelectronics. World Scientific. ISBN 978-981-02-2352-6.
8. Pavia, D. L., Lampman, G. M., & Kriz, G. S. (2014). Introduction to Spectroscopy. Cengage Learning.
9. Colthup, N. B., Daly, L. H., & Wibberley, S. E. (1990). Introduction to Infrared and RamanSpectroscopy. Academic Press.
10. Skoog, D. A., West, D. M., & Holler, F. J. (2013). Fundamentals of Analytical Chemistry.Brooks/Cole.
11. Silverstein, R. M., Webster, F. X., & Kiemle, D. J. (2005). Spectrometric Identification ofOrganic Compounds. John Wiley & Sons.
12. Colthup,N.B.,Daly,L. H.,&Wiberley,S.E.(1990).IntroductiontoInfraredandRaman Spectroscopy. Academic Press.
13. Larkin, P. (2011). Infrared and Raman Spectroscopy: Principles and Spectral Interpretation. Elsevier.
14. Pavia, D. L., Lampman, G. M., & Kriz, G. S. (2014). Introduction to Spectroscopy. Cengage Learning Larkin, P. (2011).
15. InfraredandRamanSpectroscopy:PrinciplesandSpectralInterpretation.Elsevier.
16. “InfraredSpectroscopy”.ColourLex.12March2021.Retrieved19January2022.
17. Derrick MR, Stulik D, Landry JM (1999). Infrared Spectroscopy in Conservation Science (PDF). Scientific Tools for Conservation. Getty Publications. ISBN0-89236-469-6.
18. Ricciardi P. “Unlocking the secrets
19. of illuminated manuscripts”. Retrieved11 December 2015.
20. Lau WS (1999).Infra red characterization for microelectronics. World Scientific.ISBN978- 981-02-2352-6.
21. Sengupta,S., &Jadhav,M.S.(2020).”Handheld and Portable FTIR Spectroscopy: AReview of Recent Advancements and Applications in Pharmaceutical Analysis.” Journal of Pharmaceutical and Biomedical Analysis, 178, 112909.
22. Kaufmann, S., et al. (2021). “Raman-FTIR Coupling: A New Approach to Pharmaceutical Drug Analysis.” Pharmaceutical Research, 38(2), 391-402.
23. Baker, C. S., et al. (2018). “Hyperspectral Imaging for Pharmaceutical Applications: A Review.” International Journal of Pharmaceutics, 548(1), 277-288.
24. Clarke, C. R., & Fitzpatrick, M. E. (2019). “Applications of ATR-FTIR Spectroscopy for the Pharmaceutical Industry.” International Journal of Analytical Chemistry, 2019, Article ID 7854589.
25. Guerra, L., et al. (2020). “Simultaneous Quantification of APIs and Excipients in Pharmaceutical Formulations Using FTIR and Chemometrics.” Analytica Chimica Acta, 1119, 143-150.
26. McGovern, M., & Shah, R. (2019). “Advancements in Pharmaceutical Application of Near- Infrared Spectroscopy: Focus on Recent Developments.” Journal of Pharmaceutical Sciences, 108(6), 1861-1876.
27. Kong, X., et al. (2017). “Real-time Monitoring of Pharmaceutical Manufacturing Processes Using FTIR Spectroscopy.” Journal of Pharmaceutical Innovation, 12(4), 269-277.
28. Puchades, R., et al. (2020). “Machine Learning and Spectroscopic Data in Pharmaceutical Analysis: State of the Art.” Analytica Chimica Acta, 1130, 1-18.
29. Kar, S., & Chakraborty, M. (2020). “In-situ Monitoring of Pharmaceutical Processes Using FTIR: Current Trends and Future Prospects.” Journal of Pharmaceutical Sciences, 109(6), 1719- 1729.
30. U.S. Food and Drug Administration (FDA). (2020). Guidance for Industry: Process Analytical Technology (PAT) – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. FDA.
31. Silverstein, R. M., Webster, F. X., & Kiemle, D. J. (2005). Spectrometric Identification of Organic Compounds (7th ed.). Wiley-Interscienc.
32. FDA (2000). Guidance for Industry: IR Spectroscopy in Drug Development. U.S. Food and Drug Administration.
33. Hester, R. E., & Harrison, R. M. (1995). Air Pollution and Its Impacts on the Environment(Vol. 3). Springer.
34. Belton,P.S.,&Jackson,G.S.(2003).FoodStructureandRheology.Wiley
35. :Pohl,M.,&Moritz,K.(2009).PolymerAnalysis:MethodsandApplications.Wiley-VCH.
36. Moffat, A. C., & Osselton, M. D. (2017). Clarke’s Analysis of Drugs and Poisons (4th ed.). Pharmaceutical Press.
37. VidyaSagarTheTextBookofInstrumentalMethodofDrugAnalysisbyPharmaceutical Analysis Volume-2ISBN-81-272-2132-5
38. WillardMerrittDeanSettleSeventhEditionISBN-81-239-0943-8
39. Anees A. Siddiqui, Second Edition, Volume2,By Pharmaceutical Analysis
40. Ashutosh Kar, Third Edition, The Text Book of Pharmaceutical Drug Analysis 40.https://en.wikipedia.org/wiki/nuclear-magnetic resonances -spectroscopy
41. Silverstein,R.M.,Bassler,G.C.,&Morrill,T.C.(1991).SpectrometricIdentificationof Organic Compounds (5th ed.). Wiley-Intercedence.
42. Pouchert, C. J., & Behnke, J. (2000). The Aldrich Library of 13C and 1H NMR Spectra (Vol. 1). Aldrich Chemical Co.
43. Du, Z. M., & Reibenspies, J. H. (2004). Quantitative NMR Spectroscopyin Encyclopedia of Spectroscopy and Spectrometry (2nd ed., pp. 1097-1103). Elsevier.
44. Callaghan, P. T. (2011). Principles of Nuclear Magnetic Resonance Microscopy. Oxford University Press.
45. Dumont, E., et al. (2021). “High-Resolution Magic Angle Spinning (HR-MAS) NMR: A Powerful Tool for the Study of Pharmaceutical Formulations.” Journal of Pharmaceutical and Biomedical Analysis, 195, 113849.
46. Lee, J., et al. (2019). “Applications of 2D and 3D NMR Spectroscopy in the Structural Elucidation of Pharmaceutical Compounds.” Journal of Pharmaceutical Sciences, 108(5), 1635 – 1645.
47. Koeberle, A., etal.(2020).”Applications of NMR Spectroscopy in Drug Metabolism Studies: A Review.” Journal of Pharmaceutical and Biomedical Analysis, 179, 113023.
48. López, J., et al. (2021). “Recent Developments in Quantitative NMR for the Analysis of Active Pharmaceutical Ingredients.” Analytica Chimica Acta, 1147, 63-74.
49. Sethi, S. K., et al. (2020). “NMR Spectroscopy in Polymorph Screening: Recent Advances in Pharmaceutical Applications.” International Journal of Pharmaceutics, 586, 119547.
50. Fenton, D. E., et al. (2020). “In-situ and Real-Time NMR in Pharmaceutical Manufacturing.” Journal of Pharmaceutical Innovation, 15(3), 177-186.
51. Wüthrich, K. (2020). “NMR of Biological Macromolecules: Current Trends and Developments.” Annual Review of Biophysics, 49, 145-167.
52. Ramaswamy, S., et al. (2020). “Solid-State NMR Spectroscopy in Pharmaceutical Formulation: Advancements and Applications.” International Journal of Pharmaceutics, 586, 119575.
53. Gordon, J., et al. (2021). “Applications of NMR-Based Metabolomics in Drug Discovery and Development.” Trends in Pharmacological Sciences, 42(1), 67-78.
54. O’Reilly, T. J., et al. (2020). “NMR Spectroscopy for Counterfeit Drug Detection: Advancements in Pharmaceutical Authentication.” Journal of Pharmaceutical Sciences, 109(12), 3545-3554.
55. Silverstein, R. M., Bassler, G. C., & Morrill, T. C. (2005). Spectrometric Identification of Organic Compounds (7th ed.). John Wiley & Son
56. Clore,G.M.,&Schwieters,C. D.(2006).NMR structure determination of large proteins and protein–nucleic acid complexes. Current Opinion in Structural Biology, 16(1), 53-59. https://doi.org/10.1016/j.sbi.2005.11.002
57. Viant, M.R .(2003). The role of NMR in the study of metabolomics. Current Opinion in
Biotechnology, 14(5), 17-21. https://doi.org/10.1016/S0958-1669(03)00099-8
58. Wang, C., & Mu, Y. (2011). NMR studies of protein-ligand interactions. Current Opinion in Structural Biology, 21(5), 580-586. https://doi.org/10.1016/j.sbi.2011.07.005
59. Kay, L. E., & Williamson, J. R. (1999). iNMR Techniques in Protein Structure Determination. Annual Review of Biophysics and Biomolecular Structure, 28, 1-21. https://doi.org/10.1146/annurev.biophys.28.1.1.
60. Dr.ravishankar 5th edition the text book of pharmaceutical analysis.
61. HOLLER,SKOOCE,CROUCHthetextbookof6theditionbypharmaceuticalanalysis 62.G.VIDYASAGARthetextofinstrumentalmethodofdruganalysisbypharmaceuticalanalysis
63. https://www.hunterlab.com/blog/single-beam-vs-double-beam-spectrophotometer.
64. Christian,G.D.(2004).AnalyticalChemistry.6thEdition,Wiley
65. Wilfinger,W.W.,Mackey,K.,&Wilfinger,L.(2001).”TheEffectofSolventsonUV Absorbance
of Nucleic Acids.” BioTechniques, 30(3), 510-518.
66. Forester, R. L., & Crosby, D. G. (1987). “Use of UV-Visible Spectroscopy for Environmental Monitoring.” Environmental Science & Technology, 21(3), 291-296.
67. Ahuja,S.,&Scypinski,S.(2008).HandbookofModernPharmaceuticalAnalysis.Elsevier.
68. De la Peña, D. F., & Nguyen, M. T. (2007). “UV-Visible Spectroscopy in Food Quality Control.” Food Control, 18(3), 276-280.
69. Iqbal, J., & Khurshid, M. (2020). “Portable UV-Vis Spectrophotometers for On-Site Environmental Monitoring.” Journal of Environmental Monitoring, 22(10), 1501-1509
70. Behnke, A., & Martin, S. (2021). “2D and 3D UV-Vis Spectroscopy: A New Approach for Complex Sample Analysis.” Analytica Chimica Acta, 1141, 186-195
71. Causón, R. M., & Llorent-Martínez, E. J. (2022). “Recent Trends in UV-Vis Spectroscopy Coupled with Chemometrics for Complex Sample Analysis.” TrAC Trends in Analytical Chemistry, 141, 116307.
72. Zhang, Z., & Liu, S. (2019). “Recent Advances in Surface-Enhanced UV-Vis Spectroscopy for Environmental and Biological Analysis.” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 224, 92-98
73. Sharma, P., & Ray, A. (2020). “Applications of UV-Vis Spectroscopy in Nanoparticle Characterization.” Journal of Nanoscience and Nanotechnology, 20(5), 2767-2776.
74. Arnaut, L. G., & Lamy, M. T. (1997). “UV-Vis Spectroscopy in Photochemistry.” Chemical Reviews, 97(5), 1217-1239.
75. Sharma, P., & Ray, A. (2020). “Applications of UV-Vis Spectroscopy in Nanoparticle Characterization.” Journal of Nanoscience and Nanotechnology, 20(5), 2767-2776
76. Christian,G.D.(2004).AnalyticalChemistry.6thEdition,Wiley
77. López-Nogueroles, M., & Sánchez, J. (2005). “UV-Vis Spectroscopy for the Stability Study of Pharmaceutical Products.” Pharmaceutical Science & Technology Today, 8(11), 468-475.
78. Spector, T. (2007). “Applications of UV-Vis Spectroscopy in Clinical Diagnostics.” Clinical Chemistry, 53(6), 1062-1067.